semaglutide compounding news fda Chinese companies turn to generics as shipments behind US weight-loss craze fade Compounded versions of weight loss

Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats

Filing an individual lawsuit allows injured patients in Sandy Springs and Atlanta to hold not just drug manufacturers but also negligent healthcare providers accountable

The degree and frequency of input/output verification shall be based on the complexity and reliability of the computer or related system

Postpartum weight loss goals should be approached gradually and combined with adequate nutrition, especially for breastfeeding mothers whose caloric and micronutrient demands remain elevated

12 The REWIND trial evaluated dulaglutide in a broader population, including those with a lower baseline cardiovascular risk, and demonstrated a significant reduction in composite cardiovascular outcomes, together with a favourable trend in HF-related events